Back to results
US 8,497,393 B2Granted
Process to prepare treprostinil, the active ingredient in Remodulin®
AssigneeUnited Therapeutics Corporation
InventorsHitesh Batra, Sudersan M. Tuladhar, Raju Penmasta, David A. Walsh
Life of this patent
Estimating the term…
Abstract
This present invention relates to an improved process to prepare prostacyclin derivatives. One embodiment provides for an improved process to convert benzindene triol to treprostinil via salts of treprostinil and to purify treprostinil.
Claims22
A product comprising a compound of formula I
- or a pharmaceutically acceptable salt thereof, wherein said product is prepared by a process comprising
- (a) alkylating a compound of structure II with an alkylating agent to produce a compound of formula III,
- wherein
- w=1, 2, or 3;
- Y1 is trans-CH═CH—, cis-CH═CH—, —CH2(CH2)m—, or —C≡C—;
- m is 1, 2, or 3;
- R7 is
- (1) —CpH2p—CH3, wherein p is an integer from 1 to 5, inclusive,
- (2) phenoxy optionally substituted by one, two or three chloro, fluoro, trifluoromethyl, (C1-C3) alkyl, or (C1-C3)alkoxy, with the proviso that not more than two substituents are other than alkyl, with the proviso that R7 is phenoxy or substituted phenoxy, only when R3 and R4 are hydrogen or methyl, being the same or different,
- (3) phenyl, benzyl, phenylethyl, or phenylpropyl optionally substituted on the aromatic ring by one, two or three chloro, fluoro, trifluoromethyl, (C1-C3)alkyl, or (C1-C3)alkoxy, with the proviso that not more than two substituents are other than alkyl,
- (4) cis-CH═CH—CH2—CH3,
- (5) —(CH2)2—CH(OH)—CH3, or
- (6) —(CH2)3—CH═C(CH3)2;
- —C(L1)—R7 taken together is
- (1) (C4-C7)cycloalkyl optionally substituted by 1 to 3 (C1-C5)alkyl;
- (2) 2-(2-furyl)ethyl,
- (3) 2-(3-thienyl)ethoxy, or
- (4) 3-thienyloxymethyl;
- M1 is α-OH:β-R5 or α-R5β-OH or α-OR1:β-R5 or α-R5:β-OR2, wherein R5 is hydrogen or methyl, R2 is an alcohol protecting group, and
- L1 is α-R3:β-R4, α-R4:β-R3, or a mixture of α-R3:β-R4 and α-R4:β-R3, wherein R3 and R4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R3 and R4 is fluoro only when the other is hydrogen or fluoro,
- (b) hydrolyzing the product of formula III of step (a) with a base,
- (c) contacting the product of step (h) with a base B to form a salt of formula Is.
- (d) optionally reacting the salt formed in step (c) with an acid to form the compound of formula I.
20 more elements
A product comprising a compound having formula IV
- or a pharmaceutically acceptable salt thereof, wherein the product is prepared by the process comprising
- (a) alkylating a compound of formula V with an alkylating agent to produce a compound of formula VI,
- (b) hydrolyzing the product of formula VI of step (a) with a base,
- (c) contacting the product of step (h) with a base B to form a salt of formula IVs, and
- (d) optionally reacting the salt formed in step (c) with an acid to form the compound of formula IV.
2 more elements
Dependencies are inferred from the claim text.